Home > Operations
At Alpine LifeScience, innovation is at the core of everything we do. Our R&D teams, working across multiple sites, are focused on creating advanced, affordable, and patient-centric medicines. While our current research strength lies in hemato-oncology and supportive care, our pipeline also extends to biosimilars, vaccines, complex formulations, and novel drug delivery systems.
Looking ahead, we are investing in cell and gene therapy research, with the aim of developing transformative solutions for rare and life-threatening diseases. This forward-looking approach builds on our foundation of over twenty trademarks filed across dermatology, hematology, transplantation, API polymorphs, and analytical techniques. Guided by a world-class scientific advisory board and a stage-gated R&D strategy, we are combining traditional pharmaceutical expertise with cutting-edge genetic medicine to shape the future of healthcare.
Our R&D philosophy is defined by one promise: to innovate without losing sight of affordability and accessibility. By uniting proven therapies in hemato-oncology and supportive care with next-generation research in cell and gene therapy, Alpine LifeScience is creating a pipeline that serves both today’s needs and tomorrow’s possibilities.
Alpine LifeScience partners with advanced manufacturing facilities located in India’s leading pharmaceutical hubs, ensuring that our products consistently meet global quality and safety standards. Backed by a modern analytical laboratory and a dedicated distribution center, our network is designed for efficiency, flexibility, and scalability.
Our facilities are equipped to manufacture a wide spectrum of products including APIs, formulations, biosimilars, topical and transdermal products, and wellness solutions. With the ability to manage varying batch sizes and production scales, we can respond quickly to the needs of both domestic and international markets.
All of our facilities operate under the approval and monitoring of leading national and international regulatory authorities. As we expand into Africa, South East Asia, and CIS countries, we are also strengthening our infrastructure to support next-generation biopharmaceuticals, including cell-based and gene-based therapies, ensuring that Alpine LifeScience remains at the forefront of global healthcare manufacturing.
Get In Touch